In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume 42, Issue 7, Pages 843-852
Publisher
Springer Science and Business Media LLC
Online
2023-05-03
DOI
10.1007/s10096-023-04616-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece
- (2022) Dimitra Petropoulou et al. Frontiers in Cellular and Infection Microbiology
- Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
- (2022) Helen Giamarellou et al. Antibiotics-Basel
- Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia
- (2022) Marina Gysin et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021
- (2022) Pete Kinross et al. Eurosurveillance
- Carbapenem Resistance in Acinetobacter baumannii, and their Importance in Hospital‐acquired Infections: A Scientific Review
- (2021) Marie Nguyen et al. JOURNAL OF APPLIED MICROBIOLOGY
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
- (2021) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- Antibiotics in the clinical pipeline in October 2019
- (2020) Mark S. Butler et al. JOURNAL OF ANTIBIOTICS
- Critical analysis of antibacterial agents in clinical development
- (2020) Ursula Theuretzbacher et al. NATURE REVIEWS MICROBIOLOGY
- Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use
- (2019) Masaaki Ishikawa et al. Scientific Reports
- The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
- (2019) Ilias Karaiskos et al. Frontiers in Public Health
- Dissemination of International Clone II Acinetobacter baumannii Strains Coproducing OXA-23 Carbapenemase and 16S rRNA Methylase ArmA in Athens, Greece
- (2019) Konstantina Nafplioti et al. Microbial Drug Resistance
- Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options
- (2019) Stamatis Karakonstantis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
- (2019) Ian Morrissey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model
- (2018) Anthony D. Kang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changes in antimicrobial resistance of clinical isolates of Acinetobacter baumannii group isolated in Greece, 2010–2015
- (2018) K. Dafopoulou et al. JOURNAL OF MEDICAL MICROBIOLOGY
- New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
- (2018) Burcu Isler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015
- (2018) James A. Karlowsky et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii
- (2018) Mario Juhas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predominance of international clone 2 OXA-23-producing- Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study
- (2017) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Variants of AbGRI3 carrying thearmAgene in extensively antibiotic-resistantAcinetobacter baumanniifrom Singapore
- (2017) Grace A. Blackwell et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology
- (2015) Anaïs Potron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
- (2014) Marie Abdallah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin
- (2012) T. Matt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Acinetobacter infection - an emerging threat to human health
- (2011) Paolo Visca et al. IUBMB LIFE
- Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09)
- (2011) V. Gogou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe
- (2010) K.J. Towner et al. CLINICAL MICROBIOLOGY AND INFECTION
- OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro?
- (2010) F. Grosso et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Naples, Italy, Shows the Emergence of a Novel Epidemic Clone
- (2010) M. Giannouli et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now